Calcium sensitizer levosimendan and its use in acute heart failure and related conditions

1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The principal actions of levosimendan at therapeutic concentrations are as follows: Calcium sensitization of myocytes Arterial and venous dilatation mediated via the opening of adenosine triphosphate (ATP)-sensitive potassium channels in vascular smooth muscle. This combination of actions endows levosimendan with the properties of both an energy-efficient inotrope and a balanced vasodilator. In addition, levosimendan exerts antiischemic and cardioprotective effects via potassium channels in cardiomyoctes. © 2008 Springer-Verlag London.

Cite

CITATION STYLE

APA

Mebazaa, A., Teerlink, J. R., & Pollesello, P. (2008). Calcium sensitizer levosimendan and its use in acute heart failure and related conditions. In Acute Heart Failure (pp. 595–607). Springer London. https://doi.org/10.1007/978-1-84628-782-4_55

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free